×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Hypera First Quarter 2024 Earnings: Beats Expectations
Simply Wall St
Hypera ( BVMF:HYPE3 ) First Quarter 2024 Results Key Financial Results Revenue: R$1.83b (up 7.6% from 1Q 2023). Net...
5 days ago
Hypera SA's Dividend Analysis
Yahoo Finance
Hypera SA (HYPMY) recently announced a dividend of $0.02 per share, payable on a date yet to be confirmed, with the ex-dividend date set for...
1 month ago
Unveiling Hypera SA's Dividend Performance: A Comprehensive Analysis
Yahoo Finance
Hypera SA (HYPMY) recently announced a dividend of $0.06 per share, payable on a date yet to be confirmed, with the ex-dividend date set for...
6 months ago
Hypera S.A. (BVMF:HYPE3) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Simply Wall Street
Taking into account the latest results, the consensus forecast from Hypera's ten analysts is for revenues of R$8.74b in 2024. This reflects a...
1 month ago
UBS cuts Hypera shares target, still bullish on long-term growth prospects
Investing.com India
On Monday, UBS updated its stance on Hypera SA shares, the Brazilian pharmaceutical company, by reducing its price target.
3 weeks ago
Is Hypera (BVMF:HYPE3) A Risky Investment?
Simply Wall Street
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.
2 months ago
LLY: Navigate to Success With These 4 Pharma Stocks to Buy
StockNews.com
Eli Lilly and Company(NYSE:LLY): The pharmaceutical industry is expanding due to increased demand for healthcare products and technological...
2 months ago
Brazil's Hypera Pharma to acquire drugs from Japan's Takeda for $825 million
Reuters
Brazil's Hypera Pharma said on Monday that it has signed a contract to buy a portfolio of 18 products from Japan's Takeda Pharmaceutical Co...
50 months ago
Sanofi, tightening its belt in consumer healthcare, offloads more brands to Brazil's Hypera for $190M
Fierce Pharma
Sanofi has been working to carve up its consumer healthcare business in a bid to cut costs and focus on growth drivers.
33 months ago